Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
data privacy protection Impressum

Deutsches
Krebsforschungszentrum

Research for a Life without Cancer

Link to page: New approaches against metastatic breast cancer: mini-tumors from circulating cancer cells
Latest News

New approaches against metastatic breast cancer: mini-tumors from circulating cancer cells

Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy resistance difficult. A team from the German Cancer Research Center (DKFZ), the Heidelberg Stem Cell Institute HI-STEM* and the NCT Heidelberg** has now succeeded for the first time in cultivating stable tumor organoids directly from blood samples of breast cancer patients. Using these mini-tumors, the researchers were able to decipher a molecular signaling pathway that ensures the cancer cells' survival and resistance to therapy. With this knowledge, the team was able to develop an approach to specifically eliminate these tumor cells in lab experiments.

Link to page: Joint research on the next generation of sun screens
Cooperation

Joint research on the next generation of sun screens

The German Cancer Research Center (DKFZ) and Beiersdorf are cooperating on the development of innovative sun protection products – and are working together to educate people about effective protection against harmful UV radiation.

Link to page: Double ERC success for DKFZ researchers
Award

Double ERC success for DKFZ researchers

With its "Consolidator Grants", the European Research Council (ERC) supports excellent scientists in advancing their independent careers. This year, Ana Banito (Hopp Children's Cancer Center Heidelberg/German Cancer Research Center, DKFZ) and Aurélie Ernst (DKFZ) are pleased to receive the prestigious ERC funding. Ana Banito will use the two million euros in funding to find new therapeutic approaches for the better treatment of sarcomas in children. Aurélie Ernst will use the grant to explore how and under what molecular circumstances cancer develops from cells with an unstable genome.

We are asking for your support

Your Donation for Cancer Research
Donate now

More News

Press Releases
Link to page: European Alliance to Fight Cancer in Children and Adolescents
Hopp Children’s Cancer Center Heidelberg

European Alliance to Fight Cancer in Children and Adolescents

In the presence of Queen Máxima of the Netherlands, representatives of the Prinses Máxima Centre in Utrecht, the Hopp Children's Cancer Center Heidelberg (KiTZ) and the Institut Curie in Paris signed a memorandum on strategic cooperation in European pediatric oncology in The Hague today. The "EU CAN KIDS" (European Alliance for a Childhood Without Cancer) cooperation concluded between KiTZ and Prinses Máxima Centrum in 2021 is thus being expanded to include another European partner. The alliance's research fund, which is financed with donations of 3 million euros every year, is intended to give a decisive boost to childhood cancer research in order to develop therapies with fewer side effects that are specifically tailored to children.

Link to page: Chromosomal chaos promotes therapy resistance in leukemia cells and opens up new treatment approaches
Latest News

Chromosomal chaos promotes therapy resistance in leukemia cells and opens up new treatment approaches

Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives the development of therapy resistance. Scientists from the German Cancer Research Center (DKFZ), the Heidelberg Stem Cell Institute HI-STEM* and the European Molecular Biology Laboratory (EMBL) used state-of-the-art single-cell analysis methods to analyze the cellular heterogeneity of a specific form of acute myeloid leukemia. Their data show how genetic and non-genetic factors determine the functional heterogeneity of blood cancer cells and reveal new therapeutic targets.

Link to page: Twelve scientists ranking in the top 1%
Latest News

Twelve scientists ranking in the top 1%

Twelve scientists who conduct research at the German Cancer Research Center (DKFZ) or head joint bridge departments with the DKFZ have made it to the top in 2024: they are among the leading one percent of the world's most cited researchers in their respective fields. Scientists whose work is particularly frequently cited by peers are considered to have above-average recognition in their field. Therefore, citation frequency is one of the important metrics for measuring the influence and performance of individual researchers.

Information

Search for research topic

Link to page: Selenium proteins as a possible new target for cancer research
Latest News

Selenium proteins as a possible new target for cancer research

An important enzyme helps the body produce selenium proteins – this discovery could open up new strategies for treating cancer in children. This has been published by scientists from the University of Würzburg, the University Sao Paolo, the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute HI-STEM.

Link to page: New vaccines offer hope for brain tumor patients
Award

New vaccines offer hope for brain tumor patients

Michael Platten is the winner of the "Breakthrough of the Year 2024" in the Life Sciences category of the Falling Walls Foundation.

Link to page: Language model "UroBot“ surpasses the accuracy of experienced urologists
Latest News

Language model "UroBot“ surpasses the accuracy of experienced urologists

Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. "UroBot" was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the accuracy of experienced urologists. The model justifies its answers in detail based on the guidelines.

Link to page: Critical Pathway for rare brain tumor discovered
Latest News

Critical Pathway for rare brain tumor discovered

Choroid plexus tumors mainly affect toddlers under one year of age. Scientists at the German Cancer Research Center (DKFZ) have now been able to show that a permanently activated important signaling pathway of intracellular communication is responsible for the development of these rare brain tumors.

Our research opens doors in the fight against cancer

data privacy protection

We would like to point out that data is transmitted to YouTube when viewing the video. You can find more information in our data privacy protection.

to top
powered by webEdition CMS
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy